A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma.
Year: 2008
Type: article
Study design: Clinical Trial
Source: Blood
Authors: John Gerecitano, O. O’Connor, H. Van Deventer, J. Hainsworth, J. Leonard, A. Goy, B. Afanasyev, M. Chen, K. Saikali, M. G Conlan, R Escandon, A Wolff
Institutions: Memorial Sloan Kettering Cancer Center, Columbia University Irving Medical Center, Columbia University, University of North Carolina at Chapel Hill, Sarah Cannon, Cornell University, Hackensack University Medical Center, First Pavlov State Medical University of St. Petersburg, Cytokinetics (United States)
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2564314927